Search

Your search keyword '"Tybjaerg-Hansen, Anne"' showing total 22 results

Search Constraints

Start Over You searched for: Author "Tybjaerg-Hansen, Anne" Remove constraint Author: "Tybjaerg-Hansen, Anne" Language undetermined Remove constraint Language: undetermined
22 results on '"Tybjaerg-Hansen, Anne"'

Search Results

1. Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines

2. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

3. rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis

4. Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies

5. The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation

6. The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential

7. Rare and low-frequency coding variants alter human adult height

8. Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes

9. Additional file 5: of Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: cohort studies and meta-analyses of 362,338 individuals

10. Additional file 2: of Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: cohort studies and meta-analyses of 362,338 individuals

11. Additional file 1: of Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: cohort studies and meta-analyses of 362,338 individuals

12. Additional file 5: of Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: cohort studies and meta-analyses of 362,338 individuals

13. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials

14. Association ofLPAVariants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies

15. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

16. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials

17. Additional file 4: of Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: cohort studies and meta-analyses of 362,338 individuals

18. Additional file 4: of Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: cohort studies and meta-analyses of 362,338 individuals

19. Additional file 3: of Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: cohort studies and meta-analyses of 362,338 individuals

20. Additional file 3: of Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: cohort studies and meta-analyses of 362,338 individuals

21. Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity

22. rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis

Catalog

Books, media, physical & digital resources